pimagedine has been researched along with Macular Degeneration in 2 studies
pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
aminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.
Macular Degeneration: Degenerative changes in the RETINA usually of older adults which results in a loss of vision in the center of the visual field (the MACULA LUTEA) because of damage to the retina. It occurs in dry and wet forms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoon, KD | 1 |
| Yamamoto, K | 1 |
| Ueda, K | 1 |
| Zhou, J | 1 |
| Sparrow, JR | 1 |
| Stitt, AW | 1 |
1 review available for pimagedine and Macular Degeneration
| Article | Year |
|---|---|
Advanced glycation: an important pathological event in diabetic and age related ocular disease.
Topics: Aging; Animals; Cataract; Diabetic Retinopathy; Enzyme Inhibitors; Glaucoma; Glycation End Products, | 2001 |
1 other study available for pimagedine and Macular Degeneration
| Article | Year |
|---|---|
A novel source of methylglyoxal and glyoxal in retina: implications for age-related macular degeneration.
Topics: Cells, Cultured; Chromatography, Liquid; Enzyme-Linked Immunosorbent Assay; Glycation End Products, | 2012 |